Dr. Barto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7200 Cambridge Street
Suite 8A
Houston, TX 77030Phone+1 713-798-2400Fax+1 713-798-2688
Education & Training
- Medical University of South CarolinaFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2012
- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine/Pediatrics, 2004 - 2008
- Creighton University School of MedicineClass of 2004
Certifications & Licensure
- TX State Medical License 2012 - 2025
- SC State Medical License 2008 - 2013
- PA State Medical License 2004 - 2008
Clinical Trials
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
Publications & Presentations
PubMed
- 14 citationsA phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mu...Edward F. McKone, Emily DiMango, Sivagurunathan Sutharsan, Tara Lynn Barto, Daniel Campbell
Journal of Cystic Fibrosis. 2021-03-01 - 60 citationsLumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR.Jennifer L. Taylor-Cousar, Manu Jain, Tara Lynn Barto, Tarik Haddad, Jeffrey J. Atkinson
Journal of Cystic Fibrosis. 2017-11-08 - 30 citationsA Randomized Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.Christopher H. Goss, Sonya L. Heltshe, Natalie E. West, M. Skalland, Don B. Sanders
American Journal of Respiratory and Critical Care Medicine. 2021-09-01
Press Mentions
- Cystic FibrosisMarch 28th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: